Business Description
ISIN : US78351F1075
Share Class Description:
RYAN: Class ATotal Employee Number:
6,171Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.04 | |||||
Debt-to-Equity | 7.47 | |||||
Debt-to-EBITDA | 4.84 | |||||
Interest Coverage | 2.28 | |||||
Piotroski F-Score | 7/9 | |||||
Beneish M-Score | -2.4 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 50.4 | |||||
3-Year EBITDA Growth Rate | 57.7 | |||||
3-Year EPS without NRI Growth Rate | 19.4 | |||||
3-Year FCF Growth Rate | 51.1 | |||||
3-Year Book Growth Rate | 5.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 12.19 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.88 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 62.03 | |||||
9-Day RSI | 57.73 | |||||
14-Day RSI | 56.75 | |||||
3-1 Month Momentum % | 44.73 | |||||
6-1 Month Momentum % | 16.93 | |||||
12-1 Month Momentum % | -18.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.16 | |||||
Dividend Payout Ratio | 0.23 | |||||
Forward Dividend Yield % | 1.19 | |||||
5-Year Yield-on-Cost % | 1.15 | |||||
3-Year Average Share Buyback Ratio | -4.8 | |||||
Shareholder Yield % | 1.99 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Net Margin % | 3.08 | |||||
EBITDA Margin % | 24.47 | |||||
FCF Margin % | 15.44 | |||||
OCF Margin % | 17.36 | |||||
ROE % | 16.32 | |||||
ROA % | 0.92 | |||||
ROIC % | 4.15 | |||||
3-Year ROIIC % | 2.4 | |||||
Years of Profitability over Past 10-Year | 7 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 60.93 | |||||
Forward PE Ratio | 20.26 | |||||
PE Ratio without NRI | 20.6 | |||||
Price-to-Owner-Earnings | 20.44 | |||||
PEG Ratio | 0.74 | |||||
PS Ratio | 2.09 | |||||
PB Ratio | 22.01 | |||||
Price-to-Free-Cash-Flow | 14.03 | |||||
Price-to-Operating-Cash-Flow | 12.43 | |||||
EV-to-EBIT | 30.66 | |||||
EV-to-Forward-EBIT | 7.86 | |||||
EV-to-EBITDA | 19.55 | |||||
EV-to-Forward-EBITDA | 9.71 | |||||
EV-to-Revenue | 4.79 | |||||
EV-to-Forward-Revenue | 4.53 | |||||
EV-to-FCF | 31 | |||||
Price-to-GF-Value | 0.55 | |||||
Price-to-Projected-FCF | 0.97 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.13 | |||||
Earnings Yield (Greenblatt) % | 3.26 | |||||
FCF Yield % | 4.43 | |||||
Forward Rate of Return (Yacktman) % | 25.06 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:RYAN
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Ryan Specialty Holdings Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3,217.666 | ||
| EPS (TTM) ($) | 0.72 | ||
| Beta | 0.7673 | ||
| 3-Year Sharpe Ratio | 0.06 | ||
| 3-Year Sortino Ratio | 0.09 | ||
| Volatility % | 39.9 | ||
| 14-Day RSI | 56.75 | ||
| 14-Day ATR ($) | 1.521516 | ||
| 20-Day SMA ($) | 43.1515 | ||
| 12-1 Month Momentum % | -18.78 | ||
| 52-Week Range ($) | 29.28 - 59.185 | ||
| Shares Outstanding (Mil) | 255.81 |
Piotroski F-Score Details
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ryan Specialty Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ryan Specialty Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-12 17:00 | In 168 days | ||
| Annual report for 2026 | 2027-02-12 | In 167 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-12 | In 167 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-30 16:45 | In 63 days | ||
| Third quarter earnings results for 2026 | 2026-10-30 | In 62 days | ||
| USD 0.130000 Cash Dividend | 2026-08-11 | 42.45 (+0.07%) | ||
| Second quarter earnings conference call for 2026 | 2026-07-30 17:45 | 46.48 (+2.08%) | ||
| Second quarter earnings results for 2026 | 2026-07-30 | 46.48 (+2.08%) | ||
| William Blair Growth Stock Conference | 2026-06-02 09:40 | 33.11 (+4.19%) | ||
| USD 0.130000 Cash Dividend | 2026-05-12 | 31.29 (-0.89%) |
Ryan Specialty Holdings Inc Frequently Asked Questions
Guru Commentaries on NYSE:RYAN
Ryan Specialty Holdings, Inc. reported 11.8% organic revenue growth during the first quarter. However, the company cut its 2026 organic revenue outlook to mid-single-digit growth from its prior outlook of high-single-digit growth. Despite this, we are encouraged to see the continued robust submission growth, and we believe the rate pressure is a short-term phenomenon, not a structural issue. In late May, Ryan increased its share repurchase authorization by an additional $300MM after exhausting its first ever authorization in the first five months of 2026. We added to our position in Ryan early in the quarter when its price to value ratio was more attractive.
Ryan Specialty Holdings, Inc. reported 11.8% organic revenue growth during the first quarter. However, the company cut its 2026 organic revenue outlook to mid-single-digit growth from its prior outlook of high-single-digit growth. Despite this, we are encouraged to see the continued robust submission growth, and we believe the rate pressure is a short-term phenomenon, not a structural issue. In late May, Ryan increased its share repurchase authorization by an additional $300MM after exhausting its first ever authorization in the first five months of 2026. We added to our position in Ryan early in the quarter when its price to value ratio was more attractive.
Ryan Specialty Holdings, Inc. reported 11.8% organic revenue growth during the first quarter. However, the company cut its 2026 organic revenue outlook to mid-single-digit growth from its prior outlook of high-single-digit growth. Despite this, we are encouraged to see the continued robust submission growth, and we believe the rate pressure is a short-term phenomenon, not a structural issue. In late May, Ryan increased its share repurchase authorization by an additional $300MM after exhausting its first ever authorization in the first five months of 2026. We added to our position in Ryan early in the quarter when its price to value ratio was more attractive.
Ryan Specialty Holdings, Inc. reported 11.8% organic revenue growth during the first quarter. However, the company cut its 2026 organic revenue outlook to mid-single-digit growth from its prior outlook of high-single-digit growth. Despite this, we are encouraged to see the continued robust submission growth, and we believe the rate pressure is a short-term phenomenon, not a structural issue. In late May, Ryan increased its share repurchase authorization by an additional $300MM after exhausting its first ever authorization in the first five months of 2026. We added to our position in Ryan early in the quarter when its price to value ratio was more attractive.
Ryan Specialty is a leading specialist in excess and surplus insurance, which is structurally expanding. The firm is viewed as the most capable navigator in a market that is complex and hard-to-place. While there are fears regarding AI disintermediation, we believe that Ryan Specialty's business model, which relies on human judgment for complex claims, positions it well against these concerns. The market has mispriced Ryan Specialty as an AI casualty, but we see it as a resilient business that can leverage AI to enhance its operations rather than be replaced by it.
The investment case for Ryan Specialty has been pressured by a softening insurance (pricing) cycle. We failed to recognise how quickly operating trends deteriorated. Ryan Specialty’s competitive position remains strong, and management continue to invest countercyclically in talent and technology. We have exited the position, however, and continue to monitor the pricing trends closely with a view to re-investing once the pricing environment stabilises.
Ryan Specialty Holdings (RYAN) is one of three Excess and Surplus brokers dominating the U.S. market, which is growing faster than the admitted insurance market. Despite short-term growth slowing due to a soft market and AI-related fears, RYAN has been gaining market share and has a solid double-digit growth rate. The company primarily sells complex E&S insurance, which large insurance companies trust for managing significant risks. RYAN is leveraging AI to enhance efficiency and risk assessment, positioning it to benefit from AI advancements rather than being harmed by them. We believe RYAN's strong market position and innovative use of technology make it a compelling investment.
Ryan Specialty Holdings (RYAN) is one of three Excess and Surplus brokers dominating the U.S. market, which is growing faster than the admitted insurance market. Despite short-term growth slowing due to a soft market and AI-related fears, RYAN has been gaining market share and has a solid double-digit growth rate. The company primarily sells complex E&S insurance, which large insurance companies trust over AI solutions. RYAN is leveraging AI to enhance efficiency and risk assessment, positioning it to benefit from AI advancements rather than being harmed by them. We believe RYAN's long-term prospects remain strong, and we have been buying.
Ryan Specialty Holdings (RYAN) is one of three Excess and Surplus brokers dominating the U.S. market, growing at a solid double-digit rate. Despite concerns about AI, RYAN is using AI to enhance efficiency and risk assessment, which we believe will benefit the company. The CEO of a major insurance company confirmed that they would not consider using AI instead of RYAN for complex risks, indicating strong trust in RYAN's capabilities. We have been buying RYAN as we see it as a strong player in a growing market.
The investment case for Ryan Specialty (RYAN) has been tested by a turning insurance cycle, with a weakening pricing environment impacting investor sentiment. Founder Pat Ryan noted the rapid shift in market sentiment, stating, 'What distinguishes this cycle is simple. It was harder for longer on the way up and much faster on the way down, particularly as it relates to property.' Despite Ryan Specialty's strong competitive position and management's countercyclical investments in talent and technology, the continuing weakness in end markets has led us to materially reduce the size of our investment.

